Agile Therapeutics, Inc. (AGRX) Financials

AGRX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 10.9 million 23.3 million
2023-06-30 12.6 million 24.7 million
2023-03-31 13.7 million 23.1 million
2022-12-31 14.2 million 19.8 million

AGRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 365000 439000
2023-06-30 -8.5 million 481000
2023-03-31 -1.6 million 498000
2022-12-31 -1.6 million 524000

AGRX Net Income

No data available :(

AGRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 2.9 million - 549000
2023-06-30 2.8 million - 630000
2023-03-31 4.4 million - 708000
2022-12-31 5.2 million - 785000

AGRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 3.0 million
2023-06-30 1.8 million
2023-03-31 912044
2022-12-31 824651

AGRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 705000 2.7 million 4.8 million
2023-06-30 - 703000 3.0 million 4.6 million
2023-03-31 - 763000 3.1 million 4.7 million
2022-12-31 7000 352000 2.0 million 6.8 million

AGRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 6.7 million 2.5 million
2023-06-30 5.5 million 2.3 million
2023-03-31 3.8 million 2.0 million
2022-12-31 4.0 million 1.7 million

AGRX

Price: $0.40

52 week price:
0.20
7.50

Earnings Per Share: -6.71 USD

P/E Ratio: 0.21

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 296349

Ebitda: -6.6 million

Market Capitalization: 2.5 million

Links: